Arylhydroxylamine-induced ribonucleic acid chain cleavage and chromatographic analysis of arylamine-ribonucleic acid adducts.

[1]  J. Miller,et al.  DNA adducts formed from N-benzoyloxy-N-methyl-4-aminoazobenzene in vitro and from N, N-dimethyl-4-aminoazobenzene in mouse liver. , 1981, National Cancer Institute monograph.

[2]  M. Lee,et al.  New syntheses of N-(guanosin-8-yl)-4-aminobiphenyl and its 5'-monophosphate. , 1981, Chemico-biological interactions.

[3]  J. Vaught,et al.  Evidence that arylhydroxamic acid N,O-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver. , 1980, The Journal of biological chemistry.

[4]  J. Westra,et al.  Structural identification of the pyrimidine derivatives formed from N-(deoxyguanosin-8-yl)-2-aminofluorene in aqueous solution at alkaline pH. , 1980, Carcinogenesis.

[5]  F. Beland,et al.  Acyltransferase-mediated binding of N-hydroxyarylamides to nucleic acids. , 1980, Cancer research.

[6]  J. Westra,et al.  Quantitative analysis of N-(guanin-8-yl)-N-acetyl-2-aminofluorene and N-(guanin-8-yl)-2-aminofluorene in modified DNA by hydrolysis in trifluoroacetic acid and high pressure liquid chromatography. , 1979, Cancer letters.

[7]  B. Singer.  N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis. , 1979, Journal of the National Cancer Institute.

[8]  W. Weber,et al.  Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. , 1978, Molecular pharmacology.

[9]  E. Miller.  Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.

[10]  R. Harvey,et al.  The interaction of the 7,8-dihydrodiol-9, 10-oxides of benzo(a) pyrene with bacteriophages R17 and T7. , 1977, Chemico-biological interactions.

[11]  M. Calvin,et al.  DNA strand scission by benzo[a]pyrene diol epoxides. , 1977, Science.

[12]  B. Singer.  Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity. , 1977, Journal of toxicology and environmental health.

[13]  B. Singer.  The chemical effects of nucleic acid alkylation and their relation to mutagenesis and carcinogenesis. , 1975, Progress in nucleic acid research and molecular biology.

[14]  A. Dipple,et al.  Chemical modification and biological inactivation of bacteriophage R17 by 7-bromomethylbenz(alpha)anthracenes. , 1974, Biochimica et biophysica acta.

[15]  C. King.  Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. , 1974, Cancer research.

[16]  J. Weisburger,et al.  Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids. , 1973, Pharmacological reviews.

[17]  J. Miller,et al.  Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. , 1972, Biochimica et biophysica acta.

[18]  E. Kriek.  On the mechanism of action of carcinogenic aromatic amines. II. Binding of N-hydroxy-N-acetyl-4-aminobiphenyl to rat-liver nucleic acids in vitro. , 1971, Chemico-biological interactions.

[19]  C. King,et al.  Instability of fluorenylamine-substituted polynucleotides: loss of carcinogen and production of an altered nucleic acid. , 1970, Chemico-biological interactions.

[20]  C. King,et al.  N-hydroxy-2-fluorenylacetamide. Reaction of the carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterification. , 1969, The Journal of biological chemistry.

[21]  C. Irving,et al.  Isolation of deoxyribonucleic acid and ribosomal ribonucleic acid from rat liver. , 1968, Biochimica et biophysica acta.

[22]  C. King,et al.  Enzyme-Catalyzed Reactions of the Carcinogen N-Hydroxy-2-fluorenylacetamide with Nucleic Acid , 1968, Science.

[23]  J. Miller,et al.  Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene. , 1968, Molecular pharmacology.

[24]  E. Miller,et al.  Nucleic Acid Guanine: Reaction with the Carcinogen N-Acetoxy-2-Acetylaminofluorene , 1966, Science.

[25]  E. Miller,et al.  Reaction of esters of aromatic N-hydroxy amines and amides with methionine in vitro: A model for in vivo binding of amine carcinogens to protein , 1966 .

[26]  J. Miller,et al.  The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations. , 1965, Cancer research.

[27]  E. Kriek.  On the interaction of N-2-fluorenylhydroxylamine with nucleic acids in vitro. , 1965, Biochemical and biophysical research communications.

[28]  E. Boyland,et al.  Arylhydroxylamines. Part IV. Their colorimetric determination , 1964 .

[29]  E. Miller,et al.  Urinary Metabolites of 2-Acetylaminofluorene and Related Compounds in the Rhesus Monkey , 1962 .

[30]  J. Miller,et al.  N-Hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. , 1961, Cancer research.

[31]  G. Tener.  2-Cyanoethyl Phosphate and its Use in the Synthesis of Phosphate Esters1 , 1961 .

[32]  J. Miller,et al.  The carcinogenicity of compounds related to 2-acetylaminofluorene. III. Aminobiphenyl and benzidine derivatives. , 1956, Cancer research.

[33]  R. Jenkins,et al.  Derivatives of the Hydroxydiphenyls. III. 4-Nitro-3-hydroxydiphenyl , 1937 .